These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 31164102)

  • 1. Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report.
    Cardis MA; Jiang H; Strauss J; Gulley JL; Brownell I
    BMC Cancer; 2019 Jun; 19(1):539. PubMed ID: 31164102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avelumab: a new standard for treating metastatic Merkel cell carcinoma.
    Baker M; Cordes L; Brownell I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma.
    Gaiser MR; Bongiorno M; Brownell I
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):345-359. PubMed ID: 29478343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune checkpoint inhibition in Merkel cell carcinoma].
    Terheyden P; Mohr A; Langan EA
    Hautarzt; 2019 Sep; 70(9):684-690. PubMed ID: 31468071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avelumab: A Review of Its Application in Metastatic Merkel Cell Carcinoma.
    Joseph J; Zobniw C; Davis J; Anderson J; Trinh VA
    Ann Pharmacother; 2018 Sep; 52(9):928-935. PubMed ID: 29616562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avelumab: A Novel Anti-PD-L1 Agent in the Treatment of Merkel Cell Carcinoma and Urothelial Cell Carcinoma.
    Teets A; Pham L; Tran EL; Hochmuth L; Deshmukh R
    Crit Rev Immunol; 2018; 38(3):159-206. PubMed ID: 30004857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
    Kaufman HL; Russell J; Hamid O; Bhatia S; Terheyden P; D'Angelo SP; Shih KC; Lebbé C; Linette GP; Milella M; Brownell I; Lewis KD; Lorch JH; Chin K; Mahnke L; von Heydebreck A; Cuillerot JM; Nghiem P
    Lancet Oncol; 2016 Oct; 17(10):1374-1385. PubMed ID: 27592805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy.
    Schaberg KB; Novoa RA; Wakelee HA; Kim J; Cheung C; Srinivas S; Kwong BY
    J Cutan Pathol; 2016 Apr; 43(4):339-46. PubMed ID: 26762844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma.
    Barkdull S; Brownell I
    Cancer Biol Ther; 2017 Dec; 18(12):937-939. PubMed ID: 29172995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Checkpoint Inhibitors and Beyond: An Overview of Immune-Based Therapies in Merkel Cell Carcinoma.
    Samimi M
    Am J Clin Dermatol; 2019 Jun; 20(3):391-407. PubMed ID: 30784027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for Merkel Cell Carcinoma.
    Nagase K; Narisawa Y
    Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avelumab for the treatment of metastatic Merkel cell carcinoma.
    Cordes LM; Gulley JL
    Drugs Today (Barc); 2017 Jul; 53(7):377-383. PubMed ID: 28837181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial.
    D'Angelo SP; Bhatia S; Brohl AS; Hamid O; Mehnert JM; Terheyden P; Shih KC; Brownell I; Lebbé C; Lewis KD; Linette GP; Milella M; Georges S; Shah P; Ellers-Lenz B; Bajars M; Güzel G; Nghiem PT
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series.
    Ugurel S; Spassova I; Wohlfarth J; Drusio C; Cherouny A; Melior A; Sucker A; Zimmer L; Ritter C; Schadendorf D; Becker JC
    Cancer Immunol Immunother; 2019 Jun; 68(6):983-990. PubMed ID: 30993371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avelumab: A Review in Metastatic Merkel Cell Carcinoma.
    Shirley M
    Target Oncol; 2018 Jun; 13(3):409-416. PubMed ID: 29799096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and dermoscopic features associated with lichen planus-like keratoses that undergo skin biopsy: A single-center, observational study.
    Liopyris K; Navarrete-Dechent C; Dusza SW; Marghoob AA; Deng L; Wilson BB; Marchetti MA
    Australas J Dermatol; 2019 May; 60(2):e119-e126. PubMed ID: 30450536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?
    Dasanu CA; Del Rosario M; Codreanu I; Hyams DM; Plaxe SC
    J Oncol Pharm Pract; 2019 Jan; 25(1):214-216. PubMed ID: 29933728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of fulminant type 1 diabetes induced by the anti-programmed death-ligand 1 antibody, avelumab.
    Shibayama Y; Kameda H; Ota S; Tsuchida K; Cho KY; Nakamura A; Miyoshi H; Atsumi T
    J Diabetes Investig; 2019 Sep; 10(5):1385-1387. PubMed ID: 30738003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 Inhibitor Induced Hypertrophic Lichen Planus: A Case Report.
    Lim O; Maher E; Miller DD
    Drugs R D; 2024 Jun; 24(2):353-357. PubMed ID: 38877280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial.
    D'Angelo SP; Russell J; Lebbé C; Chmielowski B; Gambichler T; Grob JJ; Kiecker F; Rabinowits G; Terheyden P; Zwiener I; Bajars M; Hennessy M; Kaufman HL
    JAMA Oncol; 2018 Sep; 4(9):e180077. PubMed ID: 29566106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.